8121
-
Therapeutics and Clinical Risk Management
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Therapeutics and Clinical Risk Management
(2,217,969) Views
Editor in Chief Professor Garry Walsh
1178-203X
Case reportBrain abscess as a manifestation of spinal dermal sinus
Parisa Emami-Naeini, Ali Mahdavi, Hamed Ahmadi, Nima Baradaran, Farideh Nejat
Therapeutics and Clinical Risk Management 2008, 4:1143-1147
02 September 2008
Review
Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides
Debra L Breneman, Timothy J Storer, John C Breneman, Diya F Mutasim
Therapeutics and Clinical Risk Management 2008, 4:1135-1141
04 August 2008
Original Research
A pilot feasibility study of daily rTMS to modify corticospinal excitability during lower limb immobilization
Raffaella Ricci, Dave Ramsey, Kevin Johnson, Jeffrey J Borckardt, Matthew Vallejo, et al
Therapeutics and Clinical Risk Management 2008, 4:1127-1134
29 August 2008
Original Research
Should patients set the agenda for informed, consent? A prospective survey of desire for information and discussion prior to routine cataract surgery
Lee Teak Tan, Huw Jenkins, John Roberts-Harry, Michael Austin
Therapeutics and Clinical Risk Management 2008, 4:1119-1125
29 August 2008
Original Research
Analysis of clinical records of dental patients attending Jordan University Hospital: Documentation of drug prescriptions and local anesthetic injections
Najla Dar-Odeh, Soukaina Ryalat, Mohammad Shayyab, Osama Abu-Hammad
Therapeutics and Clinical Risk Management 2008, 4:1111-1117
15 August 2008
Review
Assessment of acceptability and ease of use of atovaquone/proguanil medication in subjects undergoing malaria prophylaxis
V Nicosia, Giorgio Colombo, M Consentino, S Di Matteo, F Mika, et al
Therapeutics and Clinical Risk Management 2008, 4:1105-1110
01 September 2008
Original Research
Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials
Kyoko Taku, Keizo Umegaki, Yoshiko Ishimi, Shaw Watanabe
Therapeutics and Clinical Risk Management 2008, 4:1097-1103
06 July 2008
Review
Bowen’s disease – a review of newer treatment options
Thorsten Neubert, Percy Lehmann
Therapeutics and Clinical Risk Management 2008, 4:1085-1095
06 October 2008
Review
Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis
Susan S Baker
Therapeutics and Clinical Risk Management 2008, 4:1079-1084
09 October 2008
Review
Optimizing prophylactic treatment of migraine: Subtypes and patient matching
Michel Dib
Therapeutics and Clinical Risk Management 2008, 4:1061-1078
18 September 2008
Review
Weekly docetaxel in the treatment of metastatic breast cancer
Laura Palmeri, Marina Vaglica, Sergio Palmeri
Therapeutics and Clinical Risk Management 2008, 4:1047-1059
16 September 2008
Review
Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release
Mary Ann Werz
Therapeutics and Clinical Risk Management 2008, 4:1035-1046
16 September 2008
Review
Lopinavir/ritonavir in the treatment of HIV-1 infection: a review
Ashish Chandwani, Jonathan Shuter
Therapeutics and Clinical Risk Management 2008, 4:1023-1033
08 September 2008
Review
Effectiveness of twice daily azelastine nasal spray in patients with seasonal allergic rhinitis
Friedrich Horak
Therapeutics and Clinical Risk Management 2008, 4:1009-1022
11 September 2008
Review
Review of docetaxel in the treatment of gastric cancer
Eric D Tetzlaff, Jonathan D Cheng, Jaffer A Ajani
Therapeutics and Clinical Risk Management 2008, 4:999-1007
04 September 2008
Review
Risk management profile of etoricoxib: an example of personalized medicine
Paola Patrignani, Stefania Tacconelli, Marta L Capone
Therapeutics and Clinical Risk Management 2008, 4:983-997
18 August 2008
Review
Treatment of hereditary angioedema with plasma-derived C1 inhibitor
Michael J Prematta, Tracy Prematta, Timothy J Craig
Therapeutics and Clinical Risk Management 2008, 4:975-982
21 August 2008
Review
Management of postoperative ileus: focus on alvimopan
Eric L Marderstein, Conor P Delaney
Therapeutics and Clinical Risk Management 2008, 4:965-973
18 August 2008
Review
New advances in the treatment of Clostridium difficile infection (CDI)
Dennis D Hedge, Joe D Strain, Jodi R Heins, Debra K Farver
Therapeutics and Clinical Risk Management 2008, 4:949-964
18 September 2008
Review
Multi-targeted approach in the treatment of thyroid cancer
Scott N Pinchot, Rebecca S Sippel, Herbert Chen
Therapeutics and Clinical Risk Management 2008, 4:935-947
04 August 2008
Review
Treatment of Crohn’s disease with colony-stimulating factors: An overview
Luisa Guidi, Giammarco Mocci, Manuela Marzo, Sergio Rutella
Therapeutics and Clinical Risk Management 2008, 4:927-934
10 August 2008
Review
Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?
Tarsila CR Ribeiro, Julio MF Chebli, Mario Kondo, Pedro Duarte Gaburri, Liliana Andrade Chebli, Ana Cristina Amaral Feldner
Therapeutics and Clinical Risk Management 2008, 4:919-925
13 July 2008
Review
Postoperative ileus: strategies for reduction
James Lubawski, Theodore Saclarides
Therapeutics and Clinical Risk Management 2008, 4:913-917
26 August 2008
Review
Evaluation of extended and continuous use oral contraceptives
Kristen Page Wright, Julia V Johnson
Therapeutics and Clinical Risk Management 2008, 4:905-911
05 August 2008
Review
Pharmacological management of acute bronchiolitis
Melvin Wright, Charles J Mullett, Giovanni Piedimonte
Therapeutics and Clinical Risk Management 2008, 4:895-903
03 November 2008
Review
Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate
Ismail A Mohammed, Alastair J Hutchison
Therapeutics and Clinical Risk Management 2008, 4:887-893
03 November 2008
Review
Docetaxel in the treatment of squamous cell carcinoma of the head and neck
Alexander Rapidis, Nicholas Sarlis, Jean-Louis Lefebvre, Merrill Kies
Therapeutics and Clinical Risk Management 2008, 4:865-886
03 November 2008
Review
Beclomethasone/formoterol fixed combination for the management of asthma: patient considerations
Gabriele Nicolini, Nicola Scichilone, Andrea Bizzi, Alberto Papi, Leonardo M Fabbri
Therapeutics and Clinical Risk Management 2008, 4:855-864
03 November 2008
Review
Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis
Jessina C McGregor, George P Allen, David T Bearden
Therapeutics and Clinical Risk Management 2008, 4:843-853
03 November 2008
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- American Acne and Rosacea Society
The American Acne and Rosacea Society (AARS), is a 501(c)(6) non-profit organization dedicated to elevating the understanding and treatment of acne and rosacea.
